Jae Park, MD
Leukemia Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Adult Acute and Chronic Leukemias
- Lymphoproliferative Disorders
- Cellular Immunotherapy
Request an Appointment
About Me
- Chief, Cellular Therapy Service
I am a hematologist-oncologist specializing in the care of patients with leukemia. Along with other colleagues on the Leukemia Service at Memorial Sloan Kettering Cancer Center, I am dedicated to providing the best possible care by treating each patient as if he or she were a member of my own family.
Read more
As an active translational investigator, I have spent time both in the laboratory and in clinics to bring new and innovative treatments to patients with leukemia. I am particularly interested in developing more-effective and personalized therapies for patients with acute and chronic lymphoid leukemia, and am the lead investigator of a clinical trial using genetically modified T cells to treat patients with chronic lymphocytic leukemia (CLL). I am also a co-principal investigator on several other clinical trials in patients with acute lymphoblastic leukemia (ALL) and CLL.
My ultimate goal as a physician is to develop new and potentially curative therapies for patients with leukemia and to provide compassionate and individualized care to address each patient’s unique needs.
A leukemia specialist is a doctor with special training in diagnosing and treating leukemia.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Adult Acute and Chronic Leukemias
- Lymphoproliferative Disorders
- Cellular Immunotherapy
Education
- MD, Johns Hopkins School of Medicine
Residencies
- Internal Medicine - Massachusetts General Hospital
Fellowships
- Medical Hematology/Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Park sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Park
- A Phase 1 Study of 19-28z/IL-18 CAR T Cell Therapy in People With Acute Lymphoblastic Leukemia
- A Phase 1 Study of a New CAR T Cell Therapy for People With Recurrent or Persistent Large B-Cell Lymphoma
- A Phase 1 Study of ADCLEC.syn1 CAR T Cell Therapy in People With Acute Myeloid Leukemia
- A Phase 1 Study of CB-012 CAR T Cell Therapy in People With Acute Myeloid Leukemia
Read more
- A Phase 2 Study of Vemurafenib and Obinutuzumab Versus Cladribine and Rituximab in People With Untreated Hairy Cell Leukemia
- A Phase II/III Study of Calaspargase Pegol for Adults with Newly Diagnosed Philadelphia-negative Acute Lymphoblastic Leukemia
- Clinical Trials Co-Investigated by Dr. Park
- A Phase 1 Study of CD371-Targeting CAR T Cell Therapy in People With Acute Myeloid Leukemia
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Read more
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jae Park discloses the following relationships and financial interests:
-
Affyimmune Therapeutics, Inc.
Professional Services and Activities -
Allogene Therapeutics
Professional Services and Activities -
Amgen
Professional Services and Activities -
Artiva Biotherapeutics, Inc.
Professional Services and Activities -
Autolus Therapeutics
Professional Services and Activities
-
Bright Pharmaceuticals
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
Curocell Inc.
Professional Services and Activities -
Kite Pharmaceuticals
Professional Services and Activities -
Servier
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].